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We applied a combination of inorganic mesoporous silica material, frequently used as drug
carriers, and a natural organic polymer alginate (ALG), to establish a sustained drug de-
livery system for the poorly water-soluble drug Indomethacin (IND). Mesoporous silica
nanospheres (MSNs) were synthesized using an organic template method and then func-
tionalized with aminopropyl groups through postsynthesis. After drug loading into the
pores of aninopropyl functionalized MSNs (AP-MSNs), IND loaded AP-MSNs (IND-AP-MSNs)
were encapsulated by ALG through the ionic interaction. The effects of surface chemical
groups and ALG layer on IND release were systematically studied using scanning electron
microscopy (SEM), transmission electron microscopy (TEM), nitrogen adsorption, zeta-
potential analysis and TGA analysis. The surface structure and surface charge changes
of the ALG encapsulated AP-MSNs (ALG-AP-MSNs) were also investigated. The results
showed that sustained release of IND from the designed drug delivery system was mainly
due to the blockage effect from the coated ALG. We believe that this combination will help
designing oral sustained drug delivery systems for poorly water-soluble drugs.
© 2014 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
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Oral delivery is the most convenient and easily accepted
administration route for drugs. After oral administration, in
order to be absorbed into the systemic circulation, a drugmust
first be dissolved in gastrointestinal fluids. However, for
poorly water-soluble drugs, the dissolution is a rate-limiting
step in drug absorption and, so, affects the oral bioavail-
ability [1,2]. It is worth noting that nearly 40% of commercially
available drugs or new drug candidates under development
have poor water-solubility [3]. So, it is a great challenge to
enhance the dissolution rate of poorly water-soluble drugs.
Many strategies have been developed to solve this problem,
such as nanotechnology and the use of solid dispersions, but
the resulting formulations often suffer from poor stability.
In the past decade, mesoporous silica materials have
attracted the attention of pharmaceutical researchers around
theworld. Aswe know,mesoporous silicamaterials havemany
unique properties, such as their non-toxic nature, large surface
area and pore volume, tunable pore size, as well as chemically
inert and easilymodified surfaceproperties [4e9]. Various types
of such materials have been developed into drug delivery sys-
tems [10,11]. And thesematerials are consideredvery promising
to solve the problems mentioned above. When loaded using
mesoporous silica materials, the drug molecules can be sepa-
rated on the surface of these materials, and therefore the
intermolecular interactions of the crystal structure are pre-
vented, which is themain reasonwhy slow dissolution kinetics
can be avoided [12e14]. In addition, the nano-scaled drug par-
ticles,whichare inahigher freeenergystate, are confined in the
rigid porous structure, making the drug nanoparticles more
stable [14,15].Therefore,employingmesoporoussilicamaterials
as drug carriers will enhance dissolution rate and stability of
poorly water-soluble drugs. Moreover, the delivery rate
enhancement provides a foundation for further study and
investigation of the application of poorlywater-soluble drugs to
provide controlled or sustained delivery.
In order to improve patient compliance, drug efficacy and
commercial value, it is better that the drug delivery rate is
effectively controlled. And outer organic polymer coating has
become one of effective ways to regulate the drug release
pattern from mesoporous materials. H. Huang et al. have
designed a new family of folate-decorated and carbon
nanotube-mediated drug delivery system, and achieved a
controlled release of the drug doxorubicin [16]. Lizhang Sun
et al. have developed a novel chitosan encapsulated spherical
nanosilica matrix as an oral sustained drug delivery system
for poorly water-soluble drug carvedilol [15]. Chen Zhang et al.
have described a new oral drug delivery system involving a
combination of inorganic mesoporous material (CMK-5) and
organic polymer poly dimethyl diallyl ammonium (PDDA), and
achieved sustained drug release patterns for three different
poorly water-soluble drugs [17]. Apparently, the outer organic
polymer coat worked as a barrier to impede drug molecules
diffusing from the pores of mesoporous silica materials into
the outer environment. All these findings suggest that the
combination of inorganic mesoporous silica materials and
organic polymers may be a feasible and simple way to achieve
sustained drug delivery.Here, we have proposed a combination of inorganic meso-
porous silica material, used as drug carriers, and a natural
organic polymer ALG, to establish a sustained drug delivery
system for poorly water-soluble drugs. Hence, mesoporous
silica nanospheres (MSNs)were synthesized and functionalized
by aminepropyl groups. IND, a BCS class II drug (poor water
solubility and high biomenbrane permeability[18]), was chose
as a model drug and loaded into the pores AP-MSNs. Then, the
drug loaded AP-MSNs were encapsulated by ALG through the
ionic interaction between the amine on MSNs and the carboxyl
on ALG. Fig. 1 had illustrated the whole processes clearly. The
structure features of samples, as well as the effects of surface
chemical groups and the ALG layer on IND release, were sys-
tematically studied using SEM, TEM, nitrogen adsorption, zeta-
potential analysis and TGA analysis. The surface structure and
surface charge changes of the ALG encapsulated AP-MSNs
(ALG-AP-MSNs) were also investigated via BET surface area
measurement and zeta-potential measurement. We believe
that this simple combination will help designing oral sustained
drug delivery systems for poorly water-soluble drugs.2. Materials and methods
2.1. Materials
Tetraethyl orthosilicate (TEOS), hexadecyl trimethyl ammo-
nium bromide (CTAB), anhydrous ethanol (99.7%, AR), meth-
anol dried (S99.5%, AR) and sodium alginate
(viscosity ¼ 1.05~1.15 pas, the viscosity-average molecular
weight ¼ 1.30  105 ~ 2.04  105, ALG) were obtained from
Tianjin Bodi Chemical Holding Co., Ltd. Ethyl ether (S99.0%,
AR) and acetone (S99.5%, AR) were produced by Tianjin
Kaixin Chemical Industrial Co., Ltd. Indomethacin (purity
>99.0%) was kindly supplied from Shijiazhuang Pharmaceu-
tical Group (Huasheng Pharm. Co., Ltd.). All other chemicals
were commercially available and were used as purchased
without any further purification. Double distilled water was
used in all experiments.
2.2. Preparation of MSNs and AP-MSNs
MSNs were synthesized according to the solegel method re-
ported previously [19] with some modification. Briefly, 0.8 g
CTAB was dissolved in the mixture of 100 ml water and 30 ml
anhydrous ethanol under vigorous stirring at room tempera-
ture. Then 0.8 ml ammonia and 20 ml ethyl ether were added
into the solution. When the solution became homogeneous,
2.5 ml TEOS was added dropwise into the solution. The solu-
tion was kept at room temperature for 4 h under vigorous
stirring. The resulting precipitate was further homogenized
using an ATS AH100D homogenizer (ATS Engineer Inc., China)
at 800 bar for 20 cycles to reduce the aggregation of nano-
spheres. The white product was separated by centrifugation,
washed using double distilled water and anhydrous alcohol
for three times respectively, and dried at 60 C over night.
Finally, the product was calcined in air for 6 h to remove the
template and other organic residues.
MSNs were functionalized with aminopropyl groups using
the post-grafting method reported previously [20]. And the
Fig. 1 e Schematic representation of aminepropyl functionalization of MSNs, IND loaded into AP-MSNs and ALG
encapsulation.
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named as AP-MSNs.2.3. Drug loading
The drug was loaded via the solvent deposition method, and
accomplished as follows [12,14]. First, IND was dissolved in
acetone in a sealed glass bottle (20 mg/ml), and then certain
amount of the fabricated MSNs (or AP-MSNs) were added into
the solution with the drug/silica mass ratio of 1:3. After gently
stirred at room temperature over night, the mixture was dried
at 35 C in air for 24 h. Then washed in water for three times,
the white sample was placed under reduced pressure for 48 h
to remove the solvent completely. The products, named IND-
MSNs and IND-AP-MSNs were passed through the 80 mesh
sieve and placed in a vacuum dryer for further use.2.4. The encapsulation of ALG
Firstly, 400 mg IND-AP-MSNs were dispersed in 20 ml double
distilled water, and then an equal volume of the ALG solution
(2 mg/ml) was added to the suspension and shaken at 80 rpm
in a shaking incubator (THZ-82A, China) for 2 h under ambient
condition. The encapsulated particles were collected by
centrifugation at 4000 rpm for 10 min in a centrifuge (TDL-6A,
China) using “50 ml£ 6” rotating disc. The product was dried
in air at 60 C for 24 h, passed through the 80 mesh sieve and
named as ALG-IND-AP-MSNs.2.5. Morphology and structure characterization
The morphologies of products were observed using SUPRA-35
field emission SEM (ZEISS, Germany). Before analyzing, prod-
ucts were adhere to the double side adhesive carbon tape on
an aluminum stub, and then gold-sprayed under vacuum
condition. The porous structure features of the prepared
samples were observed using a TEM (Tecnai G2 F30, FEI, The
Netherlands). Prior to analysis, samples were dispersed indouble distilled water, and then being adsorbed on carbon-
plated copper grids.
The pore size distributions, specific surface areas and total
pore volumes were analyzed by an adsorption analyzer (Vsob-
2800P, China). Prior to analysis, samples were degassed under
vacuum at 60 C for 6 h. The Brunauer-Emmett-Teller (BET)
surface areas were calculated via experimental points at a
relative pressure of P/P0 ¼ 0.05e0.25. The pore size distribu-
tions (DBJH) were calculated from the desorption branch of
isotherms via the Barrett-Joyner-Halenda (BJH) method. The
total pore volumes were estimated from N2 amount adsorbed
at a relative pressure of 0.9814.2.6. The zeta-potential measurement
The zeta-potentials of MSNs and AP-MSNs, dispersed in dou-
ble distilled water, were determined on a zeta potential in-
strument (Nano-zs90, USA). And each measurement was
carried out in triplicate.2.7. Drug loading analysis
The actual drug loadings were ascertained by extracting an
accurately weighed amount of IND-loaded composites with
methanol, followed by the determination of drug content
using ultraviolet (UV) spectroscopy at a wavelength of 320 nm
(UV-2000, Unico, USA). The standard curve was linear over the
concentration range of 4.0e50.0 mg/ml. All measurements
were carried out in triplicate.2.8. TGA Analysis
To investigate the encapsulated ALG amount and exclude the
interference of the drug content changes to themeasurement,
the TGA analysis of MSNs, AP-MSNs and ALG-AP-MSNs was
carried out by TGA-50 instrument (Shimadzu, Japan) from 100
to 600 C at the heating rate of 10 C/min.
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The drug dissolution patterns were studied using a USP II
paddle method in a dissolution apparatus (ZRS-8G, Tianjin
Tianda Tianfa Technology Co., Ltd.). The paddle speed was
100 rpm and the volume of the dissolution medium, kept the
temperature at 37 ± 0.5 C, was 900 ml. Phosphate buffer so-
lution (pH ¼ 6.8) was used as the dissolution medium. At
appropriate sampling times, 5 ml samples were withdrawn
and replaced by equal volume of freshmedium instantly. Each
sample was filtered through a 0.22 mm membrane and tested
using UV spectrophotometry (UV-2000, Unico, USA) at 320 nm.
Each sample was equivalent to 25 mg IND and all the disso-
lution studies were carried out in triplicate.
2.10. Surface structure changes of ALG-AP-MSNs
In order to explore the state and the behavior of the ALG layer,
when placed in the drug release media, the BET surface area
measurement was carried out [15]. Briefly, six 50 ml. EP tubes
were prepared and each Eppendorf (EP) tube was loaded with
60mg of ALG coated blank AP-MSNs (ALG-AP-MSNs) and 30ml
pH 6.8 phosphate buffer solution. Then, after shaking for a
selected time interval at 100 rpm, and 37 C in a shaking
incubator (AHZ-82A, China), one tube was taken out and the
contents were separated by centrifugation at 4000 rpm and
dried in air under 60 C for 6 h. The specific surface area of the
dried contents was then measured by an adsorption analyzer
as mentioned above.Fig. 2 e SEM images of (A) MSNs, (B) AP-MSNs, (C2.11. Zeta-potential changes of ALG-AP-MSNs in drug
release media
To explore the interaction between the ALG layer and AP-
MSNs during the drug release, zeta-potential changes of
ALG-AP-MSNs in drug release media were measured. Briefly,
60 mg ALG-AP-MSNs were dispersed in 30 ml phosphate
buffer solution (pH 6.8). And the suspension was shaken at
100 rpm, and 37 C in a shaking incubator (AHZ-82A, China). At
selected time intervals, the zeta-potential was measured ac-
cording to the zeta-potential measurement section. Each
measurement was carried out in triplicate.3. Results and discussion
3.1. Morphology and structure characterization
As Fig. 2A and B showed, the synthesized spherical MSNs and
AP-MSNs were nearly monodispersed with an average diam-
eter of around 300 nm. From the TEM images of the MSNs,
shown in Fig. 3A, we can see that the slit-like mesopores of
MSNs were arranged radially, which would favor the mass
diffusion. N2 adsorptionedesorption isotherms of MSNs,
shown in Fig. 4, displayed a typical type IV feature with H4
hysteresis loops in accordance with the IUPAC classification
[21], indicating a narrow slit-like pore structure, which agreed
well with the results of TEM observation. It could be seen in
Fig. 5 that MSNs had a pore size distribution at 2.3 nm and) IND-AP-MSNs and (D) ALG-IND-AP-MSNs.
Fig. 3 e TEM images of (A) MSNs, (B) AP-MSNs, (C) IND-AP-MSNs and (D) ALG-IND-AP-MSNs.
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size distribution line of AP-MSNs moved to the smaller di-
rection slightly, which might be attributed to that the func-
tionalized silane were attached to the pore surface. The
synthesized MSNs had a high specific surface area of
1012.65m2/g and a large total pore volume of 0.81 cm3/g. After
functionalization, SBET and Vt were reduced, which also
demonstrated the attachment of functionalized silane [20].
Although the adsorbed amount of nitrogen reduced, the shape
of the hysteresis loop remained unchanged, whichmeans thatFig. 4 e Nitrogen adsorption/desorption isotherms of MSNs
and AP-MSNs.the pore shape was not changed much by the postsynthesis
approach. And it is in agreementwith the TEM analysis, which
is shown in Fig. 3B.
After drug loading and ALG coating, as shown in Fig. 2C and
D, the nanospheres remained almost monodispersed.
Compared with IND-AP-MSNs (shown in Fig. 3C), the edge of
which looks very smooth, a thin layer could be seen at the
edge of ALG-IND-AP-MSNs as the arrows pointed (shown in
Fig. 3D), which should due to the ALG coating on IND-AP-
MSNs. Moreover, after drug loading and ALG coating, SBETFig. 5 e Pore size distributions of MSNs and AP-MSNs.
Fig. 6 e Zeta-potentials of MSNs and AP-MSNs.
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All these findings confirm the success of drug loading and ALG
coating.
3.2. The zeta-potential measurement
In order to demonstrate the functionalization of aminopropyl
groups onMSNs, wemeasured the zeta-potentials ofMSNs and
AP-MSNs. As Fig. 6 showed, the value of MSNs was 24.3 mV,
while the zeta-potential increased to þ12.0 mV after function-
alization.This isbecause that thesilanol groupswerenegatively
charged easily under a wide range pH conditions [15,22], while
the aminopropyl groups attached on MSNs were positively
chargedwhen placed inwater [23]. The zeta-potential variation
well demonstrated the successful functionalization of amino-
propyl groups on MSNs. And the positively charged AP-MSNs
would favor the following encapsulation of the polyanion ALG.
It has been reported that the pKa values of themannuronic acid
and guluronic acid units of the ALG chain are 3.4 and 3.7,
respectively [24]. So ALG was negatively charged under the
encapsulating condition. And ALG could be encapsulated
throughtheionic interactionbetweenthepositivelychargedAP-
MSNs and the negatively charged ALG.
3.3. Drug loading and characterization
IND was loaded according to the solvent deposition method,
and then washed with water to remove the adsorbed drug on
the outer surface of the carriers, so as to expose the amino-
propyol groups for the subsequent ALG coating. And in order
to compare the drug release patterns of IND-MSNs and IND-
AP-MSNs, IND loaded MSNs were also washed with water.
As shown in Table 1, UV measurement confirmed that the
drug loading of IND could reach 18.31% for IND-MSNs and
16.44 for IND-AP-MSNs. However, during ALG coating process,
some drug loaded in AP-MSNswas lost, so the drug loading for
ALG-IND-AP-MSNs decreased to 12.73%.
3.4. TGA Analysis
In order to ascertain the encapsulated amount of alginate on
the silica nanoparticles, the TGA analysis of MSNs, AP-MSNsTable 1 e Characteristics of drug carriers before and after
drug uptake and after ALG encapsulation.
Sample DBJH
a
(nm)
SBET
b
(m2/g)
Vtc
(cm3/g)
Loading content
efficiency (%)
MSN 2.3, 3.8 1012.65 0.81
AP-MSNs 2.2, 3.6 852.42 0.60 18.31
IND-AP-
MSNs
512.75 0.43 16.44
ALG-IND-AP-
MSNs
328.91 0.34 12.73
a Dp is the pore diameter calculated by the BJH method on the
branches of the nitrogen desorption isotherms.
b SBET is the BET surface area calculated using experimental points
at a relative pressure of P/P0 ¼ 0.05 ~ 0.25.
c Vt is the total pore volume determined at a relative pressure of
0.9814.and ALG-AP-MSNs was carried out. Because some drug
might be lost during the encapsulating process, and the vari-
ation of the drug contentwill interferewith the analysis, sowe
induced this study using the samples without drug. For blank
MSNs, shown in Fig. 7, the line was almost horizontal, sug-
gesting that there was no organic residue in blank MSNs. The
line for AP-MSNs decreased 2.7%, which should due to the
weight loss of the functional groups. And the weight loss of
the functional groups and the ALG layer was 16.6% for ALG-
AP-MSNs. Therefore, we could calculate that the mass of the
ALG layer account for 13.9% of the total mass of ALG-AP-
MSNs.
3.5. In vitro drug release study
Fig. 8 showed the drug release profiles of raw IND, IND-MSNs,
IND-AP-MSNs and ALG-IND-AP-MSNs in pH 6.8 releasemedia.
Compared with raw IND, IND-MSNs showed a much faster
release pattern. The drug release within 2 h already reached
more than 90%. The immediate drug release of IND-MSNs
could be owing to the dispersing effect of MSNs with a high
surface area and the hydrophilicity of mesoporous silica
[12,14]. However, the drug release rate was a little slowed
down for IND-AP-MSNs. Under the pH 6.8 drug release media,Fig. 7 e TGA patterns of MSNs, AP-MSNs and ALG-AP-
MSNs.
Fig. 8 e Drug release profiles of raw IND, IND-MSNs, IND-
AP-MSNs and ALG-IND-AP-MSNs.
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charged, because AP-MSNs was already positively charged in
double distilled water (pH about 7.0). And indomethacin
molecules (pKa ¼ 4.5) [25] were negatively charged. So there
was ionic interaction between AP-MSNs and indomethacin,
which could be used to explain why the drug release rate was
slowed down to some extent. Moreover, the diffusion of the
drug molecules also needed to overcome the hindrance of the
alkyl chains in AP-MSNs [20]. In addition, ALG coated IND-AP-
MSNs exhibited a more sustained drug release pattern. ALG
was coated through the ionic interaction between the amine
groups on the outer surface of the drug carrier and the
carboxyl groups on ALG. The ALG layer performed a much
strong blockage effect, and the drug release was effectively
slowed down.
3.6. Surface structure changes of ALG-AP-MSNs
In order to explore the state and the behavior of the ALG layer,
when placed in the drug release media, the BET surface area
measurement was carried out in different time intervals. And
to exclude the interference of the drug release to theFig. 9 e BET surface area changes at different sampling
times.measurement, we induce this study using ALG coated blank
AP-MSNs. From Fig. 9, we can see that the SBET of ALG-AP-
MSNs sharply decreased at the beginning, and gradually in-
crease after that. The initial decrease might be caused by the
swelling of the ALG layer. When touched with the pH6.8
release media, the carboxyl groups on ALG molecule was
gradually ionized [25], making the molecule stretch and, so,
the ALG molecule occupied more space and blocked the pores
of the drug carrier. Meanwhile, the ALG layer might also be
dissolved gradually in themedia, whichmade the surface area
value start to increase.When the dissolution behavior and the
ionic interaction between the positively chargedAP-MSNs and
the negatively charged ALG reached a balance, the surface
area tended to present no significant change. Therefore, a
certain amount of swelled ALG retained on the drug carrier
and hindered the drug molecules diffusing into the release
media.
3.7. Changes of surface charge
The zeta-potentials of ALG-AP-MSNs in the drug release
media were measured in different time intervals, so as to
further investigate the interaction between the ALG layer and
AP-MSNs during the drug release. As shown in Fig. 10, when
contacting with the release media, the zeta-potential of ALG-
AP-MSNs decreased to 7.97 mV, owing to the deionization of
the carboxy groups on ALG molecule [25]. At this time, the
deionization would cause the swelling of ALG molecule,
induced by the repulsive force of the ionized carboxyl groups
on ALG molecule. And the repulsive force between ALG mol-
ecules would lead to some ALG dissolved. So the zeta-
potential started to increase. However, it should be notice
that the zeta-potential kept in the negative throughout the
whole study. This indicated that the ALG layer was not dis-
solved completely or detached fromAP-MSNs, whichmight be
attributed to the ionic interaction between the positively
charged amino groups on AP-MSNs and the negatively
charged carboxy groups on the ALG layer. Therefore, the drug
release would be hindered by the ALG layer throughout the
whole drug release process.Fig. 10 e Surface charge changes at different sampling
times.
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 1 8 3e1 9 01904. Conclusion
In summary, we have successfully developed an effective way
to control the drug release rate of a poorly water-soluble drug
and eventually obtained a sustained drug delivery system for
the poorly water-soluble drug indomethacin. MSNs were
functionalized by aminopropyl groups and used as drug car-
riers. To control the drug release rate, a natural polymer ALG
was coated on the drug loaded AP-MSNs through ionic inter-
action. The blockage effect of the ALG layer could effectively
slow down the drug release. Therefore, we believe this simple
strategy will have potential applications in producing sus-
tained drug systems for poorly water-soluble drugs. Also, this
combination of mesoporous silica materials and ALG coating
will expand the applications of inorganic materials and
polymers.
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